Abbott Laboratories NYSE: $ABT April 17, 2015 LONG av $46.25
Abbott Laboratories (NYSE: ABT) April 17, 2015 LONG av $46.25
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a wide range of products for healthcare. Abbott operates in four business segments: core pharmaceuticals, diagnostic products, nutritional products and vascular products. The pharmaceutical sector includes international sales have established a line of branded generic pharmaceuticals. The diagnostic products segment includes the sale of a line of pediatric and adult nutrition products. Nutritional products include sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and test sites for alternative care. Vascular Payment products include coronary, endovascular, structural heart, the closure of the vessel and other medical devices.